Susan Spratt, MD, senior medical director, Duke Population Health Management Office, breaks down the the prevalence of diabetes in the United States and discusses current diabetes initiatives at Duke Health.
There has been a dramatic increase in the prevance of diabetes and prediabetes in the United States, says Susan Spratt, MD, senior medical director, Duke Population Health Management Office, and associate professor of medicine, Division of Endocrinology, Metabolism, and Nutrition.
Transcript
What is the current prevalence of diabetes in our population, and how has it changed over the past decade?
Eleven percent of Americans have diabetes, that's 37 million people, and a fourth don't even know they have it. Ninety-six million people, 38% of the population, have prediabetes, and about 1 in 10 of people with prediabetes convert to diabetes within a year.
In comparison, in 1989, about 6.7 million people reported that they had diabetes. Maybe a little bit of that was underdiagnosis, but that was only 2.7% of the population. We've seen a dramatic increase in the rise of diabetes and prediabetes.
And diabetes causes devastating complications that are quite costly. In fact, the estimated cost of diabetes was $380 million in 2017, and that was nearly 6 years ago. So, figuring out how to prevent diabetes, improve diabetes, and glycemic control, and reduce complications from diabetes is essential, not just for cost, but for individuals who may be facing some of these complications.
Are there any initiatives in place at Duke Health to improve access to diabetes management services, particularly for underserved populations?
One of the biggest things we do at Duke is for all of our patients with diabetes: If they haven't had an appointment in 6 months, we reach out and try to get them scheduled to see their primary care provider. We do that at Duke PHMO [Duke Population Health Management Office], but the individual practices also have MyChart campaigns and texting campaigns to reach out to patients who have missed appointments and who really need to get in. And we see gaps in care close when patients see their primary care doctor. So number one is seeing your primary care doctor or your endocrinologist, if your endocrinologist helps you manage your diabetes.
The second thing we do is we offer care management to patients with diabetes regardless of payer; so we're payer agnostic for our care management program at PHMO. The provider does have to put in a referral and then the patient will need to accept and actually keep the visits. The visits are virtual, they're not in person.
And the third thing is, we do have diabetes education classes and nutrition that are associated with our primary care offices and our endocrinology offices. And again, you do need a referral from your doctor or diabetes provider to get an appointment, but those different things and services that we have for patients are super important. Unfortunately, they’re underutilized.
Despite Record ACA Enrollment, Report Reveals Underinsured Americans are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access and affordability to health care.
Read More
Surgeon General Calls for Action on Tobacco Use, Outcomes Disparities
November 19th 2024The new report from US Surgeon General Vivek H. Murthy, MD, MBA, highlights persistent disparities in tobacco use and secondhand smoke exposure, calling for equitable strategies to achieve a tobacco-free future.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More